NaviFUS sits in the focused ultrasound drug-delivery infrastructure layer, with BBB opening as the clearest clinical and strategic focus. Its profile is unusually advanced for the category, with multiple clinical programs, public-market access in Taiwan, and partnerships around microbubble-enabled CNS delivery.